GLOBALINKS Sep 2020

Joint health engineering symposium held with University of Queensland

Leading experts from CUHK and UQ speak on tissue engineering and healthcare technology in the joint symposium.

Leading experts from CUHK and UQ speak on tissue engineering and healthcare technology in the joint symposium.

CUHK and the University of Queensland (UQ) have been partners since 2002 and share a common vision in achieving excellence and changing the world for the better. The two universities look to forge deeper ties in areas including engineering, health sciences, medicine, and social sciences.

With the aim of cultivating ties between researchers and exploring initiatives that will capitalise on their strengths, a joint Health Engineering Virtual Symposium was organised by the Office of Academic Links (OAL) on 19 August 2020. Focusing on tissue engineering and healthcare technology, the event featured 13 speakers of different disciplines from both universities, including biomedical sciences, chemistry, dentistry, engineering, imaging, and neuroscience. The symposium was officiated by Prof. Rocky S. Tuan, Vice-Chancellor of CUHK, and Prof. Deborah Terry, Vice-Chancellor of UQ, who lent their support for deepening the relationship between the two universities. The event drew approximately 80 participants who engaged in dynamic and fruitful discussions.

The symposium marks the first of a series of events by the two universities. A joint webinar will be held on 15 October 2020 on the ethics of health during a global pandemic. For further information, please visit OAL’s website.

UQ is a leading research university consistently ranked as one of the top five universities in Australia. It has strengths in life sciences, medicine, and engineering, and performs particularly well in research commercialisation. Its innovation portfolios include Gardasil®, the world’s first HPV vaccine; Methylscape, a novel rapid cancer diagnostic technology; and its superconductor technology is used in most of the world’s MRI machines. Most recently, UQ has been dedicating to developing a COVID-19 vaccine which has moved into human trials.